Bank Of New York Mellon Corp Werewolf Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

  • $538 Trillion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$3.43 - $5.98 $234,399 - $408,661
-68,338 Closed
0 $0
Q1 2022

May 11, 2022
BUY
$3.71 - $12.22 $13,189 - $43,442
3,555 Added 5.49%
68,338 $301,000
Q4 2021

Feb 11, 2022
BUY
$11.48 - $17.65 $401,731 - $617,644
34,994 Added 117.47%
64,783 $772,000
Q3 2021

Nov 12, 2021
BUY
$13.89 - $20.31 $105,230 - $153,868
7,576 Added 34.11%
29,789 $512,000
Q2 2021

Aug 11, 2021
BUY
$11.6 - $17.44 $257,670 - $387,394
22,213 New
22,213 $387,000

Others Institutions Holding HOWL

# of Institutions
69
Shares Held
31.8M
Call Options Held
700
Put Options Held
500
View Full List

About Werewolf Therapeutics, Inc.

HOWL Quotes by TradingView
  • Ticker HOWL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,529,400
  • Market Cap $52.3M
  • Description
  • Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...
More about HOWL
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email